Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with advanced non-small cell lung cancer (NSCLC) treated with ...

President Donald Trump said ICE agents will be sent to airports to assist understaffed TSA starting March 23, amid the ...

A tumor “don’t‑eat‑me” shield also hides pro‑immune danger signals; new antibodies that unmask this hidden cue could make cancers more vulnerable to immune attack.

A Kansas City International Airport restaurant worker is charged in connection with using his cell phone to film multiple women inside the airport’s all-gender restroom.

Colorectal cancer remains one of the leading causes of cancer-related mortality worldwide, largely due to metastasis and ...

A new wave of immuno-therapies is reshaping the fight against cancer, turning the body’s own immune system into a powerful ...

Pixelgen's PNA delivers nanoscale spatial analysis of immune cell proteins at scale, as part of the company's Pixelgen Proxiome Kit. The technology is used by researchers looking for new avenues for ...

Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...

We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in ...

As TSA workers face empty paychecks and lines stretch past 2.5 hours, travelers are turning to TSA PreCheck Touchless ID for ...

Candel Therapeutics (CADL) stock rises as the company updates results from an ongoing mid-stage trial for its lead candidate, CAN-2409 in lung cancer. Read more here.

A metabolic enzyme studied for over seven decades has a hidden second function—it can unwind RNA and promote cell cycle progression, an additional function beyond its role in energy production, ...